Cost-Effectiveness Analysis Of Daclatasvir With Asunaprevir Vs Paritaprevir/Ritonavir/Ombitasvir With Dasabuvir In Treatment Of Chronic Hepatitis C In The Russian Federation

Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.400
https://www.valueinhealthjournal.com/article/S1098-3015(16)31767-3/fulltext
Section Title : Disease-Specific Studies
Section Order : 371
First Page : A415
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)31767-3&doi=10.1016/j.jval.2016.09.400
HEOR Topics :
Tags :
Regions :